The current valuation score of Processa Pharmaceuticals Inc is 6.51, ranking 290 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.51, which is -99.02% below the recent high of -0.01 and -2889.94% above the recent low of -15.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.